Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2018 May 9;13(5):e0196451.
doi: 10.1371/journal.pone.0196451. eCollection 2018.

HIV drug resistance patterns in pregnant women using next generation sequence in Mozambique

María Rupérez  1   2   3 , Marc Noguera-Julian  4   5 , Raquel González  1   2 , Sonia Maculuve  1 , Rocío Bellido  4 , Anifa Vala  1 , Cristina Rodríguez  4 , Esperança Sevene  1   6 , Roger Paredes  4   5   7 , Clara Menéndez  1   2   3
Affiliations
Observational Study

HIV drug resistance patterns in pregnant women using next generation sequence in Mozambique

María Rupérez et al. PLoS One. .

Abstract

Background: Few data on HIV resistance in pregnancy are available from Mozambique, one of the countries with the highest HIV toll worldwide. Understanding the patterns of HIV drug resistance in pregnant women might help in tailoring optimal regimens for prevention of mother to child transmission of HIV (pMTCT) and antenatal care.

Objectives: To describe the frequency and characteristics of HIV drug resistance mutations (HIVDRM) in pregnant women with virological failure at delivery, despite pMTCT or antiretroviral therapy (ART).

Methods: Samples from HIV-infected pregnant women from a rural area in southern Mozambique were analysed. Only women with HIV-1 RNA >400c/mL at delivery were included in the analysis. HIVDRM were determined using MiSeq® (detection threshold 1%) at the first antenatal care (ANC) visit and at the time of delivery.

Results: Ninety and 60 samples were available at the first ANC visit and delivery, respectively. At first ANC, 97% of the women had HIV-1 RNA>400c/mL, 39% had CD4+ counts <350 c/mm3 and 30% were previously not on ART. Thirteen women (14%) had at least one HIVDRM of whom 70% were not on previous ART. Eight women (13%) had at least one HIVDRM at delivery. Out of 37 women with data available from the two time points, 8 (21%) developed at least one new HIVDRM during pMTCT or ART. Twenty seven per cent (53/191), 32% (44/138) and 100% (5/5) of the mutations that were present at enrolment, delivery and that emerged during pregnancy, respectively, were minority mutations (frequency <20%).

Conclusions: Even with ultrasensitive HIV-1 genotyping, less than 20% of women with detectable viremia at delivery had HIVDRM before initiating pMTCT or ART. This suggests that factors other than pre-existing resistance, such as lack of adherence or interruptions of the ANC chain, are also relevant to explain lack of virological suppression at the time of delivery in women receiving antiretrovirals drugs during pregnancy.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Study profile.
See this image and copyright information in PMC

References

    1. WHO. Global update on HIV treatment 2013:results, impacts and opportunities Geneva: World Health Organization; 2013.
    1. UNAIDS/WHO. Progress Report on the Global Plan towards elimination of new HIV infections among children by 2015 and keeping their mothers alive. In: JC2509/2/E JUNPoHAaWHOU, editor. 2013.
    1. Zaba B, Calvert C, Marston M, Isingo R, Nakiyingi-Miiro J, Lutalo T, et al. Effect of HIV infection on pregnancy-related mortality in sub-Saharan Africa: secondary analyses of pooled community-based data from the network for Analysing Longitudinal Population-based HIV/AIDS data on Africa (ALPHA). Lancet. 2013;381(9879):1763–71. Epub 2013/05/21. doi: 10.1016/S0140-6736(13)60803-X . - DOI - PMC - PubMed
    1. John GC, Nduati RW, Mbori-Ngacha DA, Richardson BA, Panteleeff D, Mwatha A, et al. Correlates of mother-to-child human immunodeficiency virus type 1 (HIV-1) transmission: association with maternal plasma HIV-1 RNA load, genital HIV-1 DNA shedding, and breast infections. J Infect Dis. 2001;183(2):206–12. Epub 2000/12/20. doi: 10.1086/317918 . - DOI - PubMed
    1. Kourtis AP, Bulterys M, Nesheim SR, Lee FK. Understanding the timing of HIV transmission from mother to infant. JAMA. 2001;285(6):709–12. Epub 2001/02/15. . - PubMed

Publication types

Substances